A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer
Clinical trial NCT00833326 · COMPLETED
Trial details
- NCT number
- NCT00833326
- Sponsor
- Array Biopharma, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2010-07-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.